(Q42721362)

5 November 2017

title

Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer (English)

1 reference

5 November 2017

Shivangi Trivedi

1

1 reference

5 November 2017

Stuart C Wiber

series ordinal

2

1 reference

5 November 2017

Hala M El-Zimaity

series ordinal

3

1 reference

5 November 2017

Patricia L Brubaker

series ordinal

4

1 reference

5 November 2017

publication date

9 February 2012

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

5 November 2017

published in

1 reference

5 November 2017

volume

302

1 reference

5 November 2017

issue

8

1 reference

5 November 2017

page(s)

G840-9

1 reference

ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Crypt stem cells as the cells-of-origin of intestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Identification of stem cells in small intestine and colon by marker gene Lgr5

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Mutational analysis of Ctnnb1 and Apc in tumors from rats given 1,2-dimethylhydrazine or 2-amino-3-methylimidazo[4,5-f]quinoline: mutational 'hotspots' and the relative expression of beta-catenin and c-jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Marginal dietary thiamin deficiency induces the formation of colonic aberrant crypt foci (ACF) in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Role of intestinal inflammation as an early event in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

AOM-induced mouse colon tumors do not express full-length APC protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Doublecortin and CaM kinase-like-1 and leucine-rich-repeat-containing G-protein-coupled receptor mark quiescent and cycling intestinal stem cells, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Modeling human colon cancer in rodents using a food-borne carcinogen, PhIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Treatment of adult short bowel syndrome patients with teduglutide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Efficient method for rapid induction of aberrant crypt foci in rats with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Molecular causes of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Mouse models for the study of colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

The "cryptic" mechanism of action of glucagon-like peptide-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Cell cycle control of mammalian neural stem cells: putting a speed limit on G1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Nuclear translocation of beta-catenin in hereditary and carcinogen-induced intestinal adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Aberrant crypt foci of the colon as precursors of adenoma and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess beta-catenin gene mutations and increases immunoreactivity for beta-catenin, c

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Efficient induction of rat large intestinal tumors with a new spectrum of mutations by intermittent administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in combination with a high fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Intestinal inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00505.2011

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00505.2011

1 reference

5 November 2017

1 reference